×
SBC Medicals Price to Free Cash Flow Ratio 2023-2024 | SBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
SBC Medicals price to free cash flow ratio from 2023 to 2024. Price to free cash flow ratio can be defined as
View More
SBC Medicals Price to Free Cash Flow Ratio 2023-2024 | SBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
SBC Medicals price to free cash flow ratio from 2023 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$98B
Cencora (COR)
$48.9B
DiDi Global (DIDIY)
$23.6B
ICON (ICLR)
$17.7B
Natera (NTRA)
$16.6B
Viatris (VTRS)
$15.5B
Avantor (AVTR)
$15.4B
Revvity (RVTY)
$14.9B
BioMerieux (BMXMF)
$13.1B
CochLear (CHEOY)
$12.6B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.3B
Charles River Laboratories (CRL)
$11B
Doximity (DOCS)
$10.8B
HealthEquity (HQY)
$8.6B
Sonic Healthcare (SKHHY)
$8.5B
Bausch + Lomb (BLCO)
$7B
Life Times (LTH)
$5.2B
Sotera Health (SHC)
$4.6B
Organon (OGN)
$4.1B
Surgery Partners (SGRY)
$3.9B
BrightSpring Health Services (BTSG)
$3.4B
PACS (PACS)
$3.3B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B